ConductScience.org, home

Trial · NCT04392362

A Trial to Compare American Heart Association (AHA) and Simple (SIM)Method to Give Adenosine to Treat Supra-ventricular Tachycardia (SVT)

NCT04392362, Phase 3, Completed, University of Pretoria; results first posted 2021-06-25

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. A Trial to Compare American Heart Association (AHA) and Simple (SIM)Method to Give Adenosine to Treat Supra-ventricular Tachycardia (SVT). Trials, record NCT04392362. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04392362

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
A Trial to Compare American Heart Association (AHA) and Simple (SIM)Method to Give Adenosine to Treat Supra-ventricular Tachycardia (SVT)
NCT number
NCT04392362
Status
Completed
Phases
Phase 3
Enrollment
30 participants, actual
Lead sponsor
University of Pretoria
Conditions
Supra-ventricular Tachycardia
Interventions
Adenosine
First posted
2020-05-18
Last updated
2021-06-25
Results first posted
2021-06-25

Source ClinicalTrials.gov

Registered outcomes1

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryThe Number of Patients With First Dose Successful Termination of the Supraventricular Tachycardia to a Sinus Rhythm of Less Than 140 With the AHA Versus a Simplified Method of Adenosine Administration10 secondsThe primary outcome is the rhythm of conversion to a sinus rhythm less than 140 beat per minute.

Outcomes1

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYThe Number of Patients With First Dose Successful Termination of the Supraventricular Tachycardia to a Sinus Rhythm of Less Than 140 With the AHA Versus a Simplified Method of Adenosine Administration10 secondsparticipantsNUMBER

Results by group2

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
The Number of Patients With First Dose Successful Termination of the Supraventricular Tachycardia to a Sinus Rhythm of Less Than 140 With the AHA Versus a Simplified Method of Adenosine AdministrationIntervention Group13participants
The Number of Patients With First Dose Successful Termination of the Supraventricular Tachycardia to a Sinus Rhythm of Less Than 140 With the AHA Versus a Simplified Method of Adenosine AdministrationControl Group4participants

Participant flow6

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDIntervention/SIM Group23
Overall StudySTARTEDControl/AHA Group7
Overall StudyCOMPLETEDIntervention/SIM Group23
Overall StudyCOMPLETEDControl/AHA Group7
Overall StudyNOT COMPLETEDIntervention/SIM Group0
Overall StudyNOT COMPLETEDControl/AHA Group0

Adverse events2

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherFeeling of impending doom, dizzinessCardiac disordersIntervention Group232323
otherFeeling of impending doom, dizzinessCardiac disordersControl Group777

Adverse event totals6

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityIntervention Group023
Total, all-cause mortalityControl Group07
Total, other adverse eventsIntervention Group2323
Total, other adverse eventsControl Group77
Total, serious adverse eventsIntervention Group023
Total, serious adverse eventsControl Group07

Papers8

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
9426034RESULTPubMed
9522931BACKGROUNDPubMed
20956224BACKGROUNDPubMed
21817085BACKGROUNDPubMed
25297337BACKGROUNDPubMed
26314489BACKGROUNDPubMed
26399663BACKGROUNDPubMed
31665806BACKGROUNDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons3

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource
Intervention Group vs Control Group: The Number of Patients With First Dose Successful Termination of the Supraventricular Tachycardia to a Sinus Rhythm of Less Than 140 With the AHA Versus a Simplified Method of Adenosine Administration
Trial comparisons
Intervention Group vs Control Group: deaths from any causeTrial comparisons
Intervention Group vs Control Group: serious adverse eventsTrial comparisons

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT04392362

GET https://conductscience.org/api/trials/v1/NCT04392362/registered